Request a copy

Full Text

14

CITATIONS

14 Total citations

1 Recent citation

1.48 Field Citation Ratio

0.33 Relative Citation Ratio

publications

0

supporting

0

mentioning

0

contrasting

0

Smart Citations

0

0

0

0

Citing PublicationsSupportingMentioningContrasting

View Citations

See how this article has been cited at scite.ai

scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

• Fukuen S., Iwaki M., Yasui A., Makishima M., and Shimomura I. Sulfonylurea agents exhibit peroxisome proliferator-activated receptor gamma agonistic activity. J Biol Chem 280 (2005) 23653-23659
• Rocchi S., Picard F., Vamecq J., Gelman L., Potier N., Zeyer D., et al. A unique PPARgamma ligand with potent insulin-sensitizing yet weak adipogenic activity. Mol Cell 8 (2001) 737-747
• Maurois P., Rocchi S., Pages N., Bac P., Stables J.P., Gressens P., et al. The PPARγ agonist FMOC-l-leucine protects both mature and immature brain. Biomed Pharmacother 62 (2008) 259-263
• Jones G., Willett P., Glen R.C., Leach A.R., and Taylor R. Development and validation of a genetic algorithm for flexible docking. J Mol Biol 267 (1997) 727-748
• http://www.rcsb.org/pdb/
• http://www.chemcomp.com/
• http://www.molecular-networks.com/
• Halgren T.A. MMFF VI. MMFF94s option for energy minimization studies. J Comput Chem 20 (1999) 720-729
• http://www.chemaxon.com/
• Scarsi M., Podvinec M., Roth A., Hug H., Kersten S., Albrecht H., et al. Sulfonylureas and glinides exhibit peroxisome proliferator-activated receptor gamma activity: a combined virtual screening and biological assay approach. Mol Pharmacol 71 (2007) 398-406
• Picard F., Gehin M., Annicotte J., Rocchi S., Champy M.F., O'Malley B.W., et al. SRC-1 and TIF2 control energy balance between white and brown adipose tissues. Cell 111 (2002) 931-941
• Morosetti R., Servidei T., Mirabella M., Rutella S., Mangiola A., Maira G., et al. The PPARgamma ligands PGJ2 and rosiglitazone show a differential ability to inhibit proliferation and to induce apoptosis and differentiation of human glioblastoma cell lines. Int J Oncol 25 (2004) 493-502
• Perez-Ortiz J.M., Tranque P., Vaquero C.F., Domingo B., Molina F., Calvos S., et al. Glitazones differentially regulate primary astrocyte and glioma cell survival. Involvement of reactive oxygen species and peroxisome proliferator-activated receptor-gamma. J Biol Chem 279 (2004) 8976-8985
• Renaud J., Rochel N., Ruff M., Vivat V., Chambon P., Gronemeyer H., et al. Crystal structure of the RAR-[gamma] ligand-binding domain bound to all-trans retinoic acid. Nature 378 (1995) 681-689
• Zoete V., Grosdidier A., and Michielin O. Peroxisome proliferator-activated receptor structures: ligand specificity, molecular switch and interactions with regulators. Biochim Biophys Acta 1171 (2007) 915-925